Triazolam (Halcion) is a prescription medicine in the benzodiazepine drug class used for the short-term management of insomnia (difficulty sleeping). Triazolam and other benzodiazepines are highly addictive and should be used cautiously.
What is Chlorotriazolam?
Triazolam and other benzodiazepines bind to specific places in your brain called “benzodiazepine receptors,” and can make you feel tired and relaxed. The effect of benzodiazepines, in general, makes them an effective option for treating sleep problems in the short term.
How to take Halcion?
Triazolam interacts directly with a specific site on the gamma-aminobutyric acid (GABA)-A-chloride-ionophore receptor complex located on the neuronal membrane. Binding causes allosteric modification of the receptor and modulation of its affinity for the inhibitory neurotransmitter GABA. This results in enhancement of synaptic actions of GABA and includes an increase in the frequency of chloride channel openings, increased chloride ion conductance, membrane hyperpolarization and ultimately synaptic inhibition and decreased neuronal excitability.
What is Triclazolam used for?
Triazolam targets neuroreceptors that regulate brain function. This slows hyperactive brain activity and promotes deeper sleep. The substance is sometimes referred to by the slang term “Up Johns.” Triazolam has a much shorter half-life than other Benzodiazepine. Halcion’s half-life, or how long the drug remains active in the body, is only 1 to 2 hours. Other Benzos can last up to 70 hours.
Effects of Hypam?
Triazolam belongs to the Pregnancy Category X of the FDA. It is known to have the potential to cause birth defects. Benzodiazepines require special precautions if used in the elderly, during pregnancy, in children, in alcoholics, or in other drug-dependent individuals and individuals with comorbid psychiatric disorders.
How long does Apo-Triazo last in the body?
The pharmacological effects of triazolam are similar to those of most other benzodiazepines. It does not generate active metabolites. Triazolam is a short-acting benzodiazepine, is lipophilic, and is metabolised hepatically via oxidative pathways.